|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Nabriva Therapeutics (NASDAQ: NBRV) through any online brokerage.
There are no as such competitors for Nabriva Therapeutics.
The latest price target for Nabriva Therapeutics (NASDAQ: NBRV) was reported by Morgan Stanley on December 7, 2020. The analyst firm set a price target for 20.00 expecting NBRV to rise to within 12 months (a possible 1669.91% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Nabriva Therapeutics (NASDAQ: NBRV) is $1.13 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Nabriva Therapeutics.
Nabriva Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Nabriva Therapeutics.
Nabriva Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.